Reductions in Bone Mineral Density Are Apparent Early in Children With Prevalent Osteonecrosis Lesions Following Leukemia Therapy

Osteonecrosis (ON) is a serious complication of childhood acute lymphoblastic leukemia. We determined the prevalence of osteonecrotic lesions in our patient population by a one‐time multisite magnetic resonance imaging (MRI) more than 1 year following leukemia therapy. MRI findings were evaluated in relationship to clinical factors (including longitudinal changes in bone mineral density [BMD]). Eighty‐six children enrolled in the Steroid Associated Osteoporosis in the Pediatric Population (STOPP) study were evaluated for ON at 3.1 ± 1.3 years following therapy. Thirty children had a total of 150 confirmed ON lesions (35%). Lumbar spine (LS) BMD Z‐scores (mean ± SD) were low at diagnosis and similar between patients with and without ON (−1.09 ± 1.53 versus −1.27 ± 1.25, p = 0.549). LS BMD Z‐scores declined from baseline to 12 months in children with ON (−0.31 ± 1.02) but not in those without (0.13 ± 0.82, p = 0.035); the hip BMD Z‐scores from baseline to 24 months declined in both groups, but to a greater extent in those with ON (−1.77 ± 1.22) compared to those without (−1.03 ± 1.07, p = 0.045). At the time of the MRI, mean total hip and total body (TB) BMD Z‐scores were lower in children with ON (hip −0.98 ± 0.95 versus −0.28 ± 1.06, p = 0.010; TB −1.36 ± 1.10 versus −0.48 ± 1.50, p = 0.018). Pain occurred in 11/30 (37%) with ON versus 20/56 (36%) without, p = 0.841. In multivariable models, older age at diagnosis (odds ratio [OR] 1.57; 95% confidence interval [CI], 1.15–2.13; p = 0.004), and hip BMD Z‐score at MRI (OR 2.23; 95% CI, 1.02–4.87; p = 0.046) were independently associated with ON. Overall, one‐third of children demonstrated ON after leukemia therapy. Those with ON had greater reductions in spine and hip BMD Z‐scores in the first 1 and 2 years of therapy, respectively. Older age and lower hip BMD Z‐scores at MRI were significantly associated with prevalent, off‐therapy ON. These data assist in identifying children at risk of ON. © 2023 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).

[1]  C. Morris,et al.  Bisphosphonate Therapy for Treating Osteonecrosis in Pediatric Leukemia Patients: A Systematic Review. , 2020, Journal of pediatric hematology/oncology.

[2]  M. Relling,et al.  Incidence of hip and knee osteonecrosis and their associations with bone mineral density in children with acute lymphoblastic leukaemia , 2020, British journal of haematology.

[3]  Pio Zeppa,et al.  Non-Hodgkin Lymphoma. , 2020, Monographs in clinical cytology.

[4]  A. Borkhardt,et al.  Osteonecrosis in children with acute lymphoblastic leukemia at initial diagnosis and prior to any chemotherapy , 2019, Leukemia & lymphoma.

[5]  J. Jaremko,et al.  Bone Morbidity and Recovery in Children With Acute Lymphoblastic Leukemia: Results of a Six‐Year Prospective Cohort Study , 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  B. Zemel,et al.  Changes in pediatric DXA measures of musculoskeletal outcomes and correlation with quantitative CT following treatment of acute lymphoblastic leukemia. , 2018, Bone.

[7]  J. Harbott,et al.  Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000. , 2016, Blood.

[8]  D. Little,et al.  Incidence and outcome of osteonecrosis in children and adolescents after intensive therapy for acute lymphoblastic leukemia (ALL) , 2016, Cancer medicine.

[9]  J. Downing,et al.  Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  J. Jaremko,et al.  Incident Vertebral Fractures in Children With Leukemia During the Four Years Following Diagnosis. , 2015, The Journal of clinical endocrinology and metabolism.

[11]  R. Pieters,et al.  Aggravated bone density decline following symptomatic osteonecrosis in children with acute lymphoblastic leukemia , 2015, Haematologica.

[12]  J. Downing,et al.  Utility of early screening magnetic resonance imaging for extensive hip osteonecrosis in pediatric patients treated with glucocorticoids. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  W. Hop,et al.  Bone mineral density at diagnosis determines fracture rate in children with acute lymphoblastic leukemia treated according to the DCOG-ALL9 protocol. , 2014, Bone.

[14]  P. Auquier,et al.  Symptomatic osteonecrosis in childhood leukemia survivors: prevalence, risk factors and impact on quality of life in adulthood , 2013, Haematologica.

[15]  A. Nettel-Aguirre,et al.  Widespread Osteonecrosis in Children With Leukemia Revealed by Whole-body MRI , 2012, Clinical orthopaedics and related research.

[16]  H. Sather,et al.  Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial. , 2012, The Lancet. Oncology.

[17]  S. Taback,et al.  High incidence of vertebral fractures in children with acute lymphoblastic leukemia 12 months after the initiation of therapy. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  F. Rauch,et al.  The dynamics of bone structure development during pubertal growth. , 2012, Journal of musculoskeletal & neuronal interactions.

[19]  W. Hop,et al.  Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  T. Hangartner,et al.  Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the bone mineral density in childhood study. , 2011, The Journal of clinical endocrinology and metabolism.

[21]  D. Peck Slipped capital femoral epiphysis: diagnosis and management. , 2010, American family physician.

[22]  S. Kaste,et al.  How Does Osteonecrosis About the Knee Progress in Young Patients with Leukemia?: A 2- to 7-year Study , 2010, Clinical orthopaedics and related research.

[23]  D. Moher,et al.  Advanced Vertebral Fracture Among Newly Diagnosed Children With Acute Lymphoblastic Leukemia: Results of the Canadian Steroid‐Associated Osteoporosis in the Pediatric Population (STOPP) Research Program , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[24]  R. Pieters,et al.  Impaired dexamethasone-related increase of anticoagulants is associated with the development of osteonecrosis in childhood acute lymphoblastic leukemia , 2008, Haematologica.

[25]  M. Relling,et al.  A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group. , 2008, Blood.

[26]  R. Barr,et al.  Osteonecrosis in children and adolescents with cancer , 2008, Pediatric blood & cancer.

[27]  E. Pääkkö,et al.  High body mass index increases the risk for osteonecrosis in children with acute lymphoblastic leukemia. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  C. Pui,et al.  Femoral head osteonecrosis in pediatric and young adult patients with leukemia or lymphoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  R. Barr,et al.  Osteonecrosis in children and adolescents with cancer - an adverse effect of systemic therapy. , 2007, European journal of cancer.

[30]  P. Lafforgue Pathophysiology and natural history of avascular necrosis of bone. , 2006, Joint, bone, spine : revue du rhumatisme.

[31]  S. Rai,et al.  MRI of knee osteonecrosis in children with leukemia and lymphoma: Part 1, observer agreement. , 2006, AJR. American journal of roentgenology.

[32]  S. Richards,et al.  Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial , 2005, British journal of haematology.

[33]  M. Schrappe,et al.  Osteonecrosis: A treatment related toxicity in childhood acute lymphoblastic leukemia (ALL)—experiences from trial ALL‐BFM 95 , 2005, Pediatric blood & cancer.

[34]  Tjeerd P van Staa,et al.  Epidemiology of Childhood Fractures in Britain: A Study Using the General Practice Research Database , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[35]  T. Kubo,et al.  The 2001 revised criteria for diagnosis, classification, and staging of idiopathic osteonecrosis of the femoral head , 2002, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[36]  E. Krenning,et al.  Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia. , 2002, The Journal of pediatrics.

[37]  M. Levien Osteonecrosis as a Complication of Treating Acute Lymphoblastic Leukemia in Children: A Report From the Children's Cancer Group , 2002, Clinical pediatrics.

[38]  R. Gelber,et al.  Bony morbidity in children treated for acute lymphoblastic leukemia. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  C. Pui,et al.  Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphoma , 2001, Leukemia.

[40]  H. Sather,et al.  Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  A. Parfitt,et al.  Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. , 1998, The Journal of clinical investigation.

[42]  S. Atkinson,et al.  Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[43]  M. Nevitt,et al.  Vertebral fracture assessment using a semiquantitative technique , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[44]  C. Rosen,et al.  Validation of a quantitative food frequency questionnaire for rapid assessment of dietary calcium intake. , 1989, Journal of the American Dietetic Association.

[45]  M. Reed,et al.  Orthopaedic manifestations of leukemia in children. , 1986, The Journal of bone and joint surgery. American volume.

[46]  M. Kransdorf,et al.  From the Radiologic Pathology Archives 1 Imaging of Osteonecrosis : Radiologic-Pathologic Correlation 2 , 2014 .

[47]  M. Relling,et al.  Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia. , 2010, Blood.

[48]  M. Relling,et al.  A PAI-1 ( SERPINE 1 ) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia : a report from the Children ’ s Oncology Group , 2008 .

[49]  H. Pan,et al.  WHO child growth standards: length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age , 2006 .

[50]  A. Colevas,et al.  The NCI Common Terminology Criteria for Adverse Events (CTCAE) v 3.0 is the new standard for oncology clinical trials. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  Lester R Curtin,et al.  Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. , 2002, Pediatrics.

[52]  E. Pääkkö,et al.  Osteonecrosis during the treatment of childhood acute lymphoblastic leukemia: a prospective MRI study. , 1999, Medical and pediatric oncology.

[53]  its Panel on Folate,et al.  STANDING COMMITTEE ON THE SCIENTIFIC EVALUATION OF DIETARY REFERENCE INTAKES , 1998 .

[54]  C. Pui,et al.  Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.